Fig. 6From: A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studiesDose-dependent antiproliferative activity of doxorubicin (a) and dasatinib (b) against BD and DH82 cells after 72Â h of treatment. Cells treated with vehicle DMSO were used as control cellsBack to article page